Scientific Officer

IterOnco is an innovative French biotechnology start-up. Founded in July 2024 and located in the Paris-Saclay University Park, IterOnco is dedicated to advancing cancer treatment and enhancing clinical outcomes through innovation and quality services. Our internal R&D efforts are focused specifically on enhancing NK cell immunotherapy for solid cancer treatment. In contrast, our external scientific and regulatory consulting services span a broad range of oncology fields. We offer support in project management, study and protocol development, data analysis, scientific publications, regulatory documents, and will introduce advanced preclinical in vitro services in 2025, which will provide critical insights across various cancer therapeutic areas.

**Poste et missions**:
- Managing and analyzing data to support research outcomes.
- Publishing and presenting scientific findings in high-impact journals and at international conferences.
- Assisting with the setup of IterOnco’s cellular, molecular, and pharmacology lab.
- Selecting service providers for outsourced pharmacology, toxicology, and manufacturing activities.
- Managing and monitoring experiments conducted by academic partners and outsourced activities.
- Writing scientific and regulatory documents.
- Collaborating with clinical operations and regulatory agencies to transition promising treatments from preclinical to clinical stages.
- Leading or participating in the design and execution of preclinical studies and preparation of clinical trial authorization documents.
- Leading and mentoring junior scientists and research associates, fostering a collaborative and productive research environment.

**Mobilité géographique**:

- Pas de déplacement**Profil**:

- Ph.D. in Molecular and Cellular Biology, Immunology, Pharmacology, or a related field.
- Proficiency in English and French.
- Strong problem-solving, data analysis and writing skills.
- Motivated by teamwork and continuous learning, with the ability to work independently or as part of a group.